Skip to main content
Alvotech (ALVO)
NASDAQ: ALVO · IEX Real-Time Price · USD
11.94
+0.03 (0.25%)
At close: Jul 19, 2024, 4:30 PM
11.91
-0.03 (-0.25%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Alvotech Revenue

Alvotech had revenue of $114.39M in the twelve months ending March 31, 2024, with 14.27% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $36.89M with 132.29% year-over-year growth. In the year 2023, Alvotech had annual revenue of $93.38M with 9.84% growth.

Revenue (ttm)
$114.39M
Revenue Growth
+14.27%
P/S Ratio
31.52
Revenue / Employee
$111,494
Employees
1,026
Market Cap
3.61B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202393.38M8.37M9.84%
Dec 31, 202285.02M45.33M114.23%
Dec 31, 202139.68M-29.77M-42.86%
Dec 31, 202069.45M-13.23M-16.00%
Dec 31, 201982.68M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Surgery Partners 2.79B
Prestige Consumer Healthcare 1.13B
Sotera Health Company 1.08B
Neogen 929.24M
Waystar Holding 824.72M
Guardant Health 603.73M
Corcept Therapeutics 523.53M
PROCEPT BioRobotics 156.33M
Revenue Rankings

ALVO News

More News